MedPath
PPB Approval

CO-AMOXICLAV DRY SUSP 200/28.5MG (BF)

HK-50392

Prescription only Medicines

November 16, 2002

bright future pharmaceuticals factory o/b bright future pharmaceutical laboratories limited

Company Information

Company Details

bright future pharmaceuticals factory o/b bright future pharmaceutical laboratories limited

BF PHARMACEUTICAL CTR NO.1 & 8 WANG FU ST, YUEN LONG INDUSTRIAL ESTATE, YUEN LONG, NEW TERRITORIES

Active Ingredients

amoxicillin (as trihydrate)

clavulanic acid (as potassium clavulanate)

Drug Monographs

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

CO-AMOXICLAV DRY SUSP 200/28.5MG (BF) - PPB 批准文号 | MedPath